(PharmaNewsWire.Com, April 16, 2019 ) MARKET INTRODUCTION Atrial fibrillation is arrhythmias that refers to an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Technical development in the field of surgical catheter ablation along with rising occurrence of disease due to changes lifestyle habits like drinking and smoking will drive the growth of global atrial fibrillation device market in forecast period.
MARKET DYNAMICS The atrial fibrillation market is anticipated to grow in the forecast period owing to driving factors such as rise in the prevalence of obesity and hypertension in elderly population, reduced mortality rate and favorable outcomes of the atrial fibrillation devices. However, the catheter related complications and high cost of minimally invasive ablation procedures eventually hinders the market growth.
Some of the Major Players In Atrial Fibrillation Market: AtriCure Inc. Biosense Webster Inc. Boehringer Ingelheim GmbH Boston Scientific Corporation Bristol- Myers Squibb Corporation Cardio Focus Inc. Endoscopic Technologies Inc. Sanofi Abbott Johnsons & Johnson Services, Ltd.
MARKET SCOPE The "Global Atrial Fibrillation Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of atrial fibrillation market with detailed market segmentation by treatment type, end user and geography. The global atrial fibrillation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading atrial fibrillation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION The global atrial fibrillation market is segmented on the basis of treatment type and end user. Based on treatment type, the market is segmented as non-pharmacological and pharmacological. The atrial fibrillation market, based on end user is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.
REGIONAL FRAMEWORK The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global atrial fibrillation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The atrial fibrillation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
About Us The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
